As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The market for stem cell is being driven by the rising prevalence of various health-related issues. As orthopaedic injuries and trauma cases caused by accidents are significantly surging, stem cell therapy is being deployed in the treatment of various bone-joint injuries, such as femoral head, osteogenesis imperfecta, and spinal bone defects, among others, which is augmenting the market growth. Moreover, increasing research and development (R&D) activities to deploy stem cell therapy as a potential treatment for arthritis and osteoporosis is expected to drive the market growth. In addition, various measures undertaken by both governments and other organisations to increase the awareness regarding the benefits of stem cell is projected to propel the market growth.
Some of the leading players in the market are Becton, Dickinson and Company (NYSE: BDX) and Cellular Engineering Technologies. In November 2018, the latter, along with John Paul II Medical Research Institute and the University of Iowa, announced a new milestone in regenerative medicine to create safer pluripotent stem cells from cord blood and peripheral blood obtained from donors. The findings examined a new approach to create induced pluripotent stem cells (iPSC) without utilising viruses and standard oncogenes. The study demonstrated the creation of iPSC from peripheral blood in patients with Cystic Fibrosis and alpha one antitrypsin deficiency, a cause of Chronic Obstructive Pulmonary Disease. It also provided a safer autologous pluripotent stem cell for future use as the technology can provide personalised and regenerative medicine, drug discovery, and bio-banking. Such research and studies to discover advanced and innovative methods are expected to augment the market growth in the coming years.
Market Analysis by Product Type, Treatment Type, Application, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global stem cell market are Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.